Fasting & Inflammation
topic
Fasting — including intermittent fasting, time-restricted eating, and extended fasting — reduces systemic inflammation through multiple mechanisms: reduction of circulating glucose and insulin (reducing glycation-driven inflammation), activation of AMPK (which inhibits NF-κB, the master inflammatory transcription factor), promotion of autophagy (removing damaged cellular components that activate inflammasomes), reduction of visceral adipose tissue (the primary source of inflammatory adipokines), and beneficial modulation of gut microbiome composition.
Role
Fasting as an anti-inflammatory intervention represents one of the most ancient and most scientifically validated health practices — with Ramadan fasting studies, clinical fasting research, and animal models consistently demonstrating inflammation reduction through the mechanisms above. The anti-inflammatory benefit provides a mechanistic rationale for fasting that transcends weight management — explaining why conditions as diverse as rheumatoid arthritis, multiple sclerosis, asthma, and metabolic syndrome improve with fasting interventions, and providing a framework for understanding fasting that makes it a specific therapeutic tool rather than simply a caloric restriction strategy.